Streamlining Your US Expansion – A Thought Leadership Chat
15 October 2021
Are you considering 成长th into the US market in 2021/22? Join our Managing Director, Nora Rothrock, for a Streamlining Your US Expansion free webcast, hosted by Wilson Sonsini, where you can access an array of eminent advisors who can support UK businesses with US investment aspirations. We will explore the comprehensive operational support needed to establish, 成长, and streamline your US expansion activity. Get ready to learn more about what you need to know and plan for in your US expansion and tools you can leverage.
Experts from Wilson Sonsini, 美国税务 & Financial 服务, and Silicon Valley Bank – UK Branch will all join a panel moderated by Dr. 弗兰克·列文 as we address topics covering:
- 启动
- Incorporation & 位置
- Marketing approach
- 招聘
- 移民 & 签证
- 一般
- Scaling – Fundraising from US VCs
- 退出
This online-只有 event will take place on 15 October from 2:30-4:00 pm (BST).
主持人:
Dr. 弗兰克·列文 (主要, Blue Link Worldwide UK) is a US citizen and UK national who has spent a lifetime as a senior international executive having lived & worked in both countries.
主持人:
Sonya Iovieno (Head of Venture & Growth, Silicon Valley Bank – UK Branch) heads up the Venture & Growth division of Silicon Valley Bank’s UK Branch. Sonya joined SVB from Lloyds Bank in September 2016, where she was responsible for new business origination with mid-market companies. Sonya brings 20 years of corporate and commercial banking experience. At Silicon Valley Bank, Sonya is focused on high 成长th venture capital-backed businesses that have typically raised Series A financing helping them to scale until they exit or become profitable.
Nora Rothrock (Group Managing Director, 美国税务 & Financial 服务) is a commercially-focused Managing Director with extensive experience in UK, European and US strategy. She regularly advises emerging and scale-up companies on 成长th and commercial strategies, including US Expansion and business transformation.
Daniel Glazer (合作伙伴, Wilson Sonsini) advises UK/European tech and life sciences companies on raising US capital and expanding their businesses into US markets.